On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
On Sept. 13, 2022, Novavax and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer…
On Sept. 12, 2022, the White House announced an executive order to advance biotechnology and biomanufacturing towards innovative…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 8, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service launched an updated…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
On Sept. 6, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service had reviewed…
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Sept. 3, 2022, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) has…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Sept. 2, 2022, Novavax announced that the World Health Organization had approved a variation to allow SK…
On Sept. 1, 2022, Novavax announced that Nuvaxovidï¾™ (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…
On Aug. 29, 2022, the U.S. Department of Health and Human Services announced it had provided approximately $11…
On Aug. 26, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency in the United Kingdom…
On Aug. 26, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
On Aug. 24, 2022, BioMarin Pharmaceutical announced that the European Commission (EC) had granted conditional marketing authorization (CMA)…
On Aug. 23, 2022, Moderna announced that it has completed its submission to the U.S. Food and Drug…
On Aug. 23, 2022, Pfizer and BioNTech announced updated efficacy results from a Phase 2/3 trial evaluating a…
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
On Aug. 23, 2022, Moderna announced that the Government of Canada had exercised its option to purchase an…
On Aug. 22, 2022, Pfizer and BioNTech announced they had completed a submission to the U.S. Food and…
On Aug. 19, 2022, Novavax announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received expanded emergency use…
On Aug. 18, 2022, Novavax announced that New Zealand’s Medsafe has granted expanded provisional approval for Nuvaxovid (NVX-CoV2373)…
On Aug. 18, 2022, the White House announced that the HHS had accelerated Phase 4 of its National…
On Aug. 17, 2022, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel) developed by bluebird bio,…